Early and systematic oncosexological supporting care
Early and systematic oncosexological supporting care: Each patient included in the study will be cared by an anthropologist and a sexologist.
This therapeutic support care will be based on :
* 2 qualitative semi-directive interviews (Baseline and M18),
* 2 individual consultations with questionnaires (Baseline and M18).
The qualitative semi-structured interviews will be conducted with the anthropologist, and the individual consultations with the sexologist.
At the end of the first oncosexology consultation, patients will be given the opportunity to decide whether or not to accept further systematic oncosexology support care, which will be based on :
* 3 individual and/or couple consultations,
* 3 group workshops.
Patients are under no obligation to accept this additional oncosexology support care.
Study summary
The aim of this clinical trial is to compare the benefit of early, systematic, multidisciplinary oncosexological care versus on-demand care on the sexual health of women with breast cancer.
Eligibility
Sex
FEMALE
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria:
* Women ≥ 18 years (menopausal or not),
* Localized breast cancer with or without lymph node involvement,
* Initial treatment starting with surgical resection, whatever the associated therapy (chemotherapy, radiotherapy, hormone therapy, monoclonal antibody, conjugated drug antibody, targeted therapy such as cyclin and anti-PARP inhibitors, etc.),
* Patient affiliated or benefiting from the social security system,
* Patient informed and informed consent signed.
Exclusion Criteria:
* History of cancer (except squamous cell carcinoma or basal cell carcinoma) in the last five years,
* Pregnant or breast-feeding women,
* Patients deprived of their liberty, under guardianship or curatorship and all other administrative safeguards,
* Patients unable to comply with the study schedule for social, medical or psychological reasons.
Primary outcome measure(s)
Sexual satisfaction — Measured at baseline and at 18 months following initiation of treatment and surgical. Sexual satisfaction score measured by self-questionnaire using the EORTC Quality of Life Questionnaire Sexual Health scale (EORTC QLQ-SH22).
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.
